20 Years
N/A
Both
Cancer, Cytomegalovirus
Trial Information
Despite CMV reactivation has been clearly described in patients underwent transplantation,
this phenomenon has not been studied in patients undergoing chemotherapy. Our purpose is to
understand if CMV number increases in monocytic leukocytes during chemotherapy and how is
the host response to that changes.
Virus load will be studied by quantitative PCR, host response will be studied by measuring
patient's anti-CMV IgG, CMV-associated symptoms, serum IFN-r and TNF-a.
Inclusion Criteria:
- clinical diagnosis of any cancer
- chemotherapy is needed for more than 6 months
- age>20 years old
Exclusion Criteria:
- those who do not agree to participate
Type of Study:
Observational
Study Design:
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Yen-Ta Lu, MD, PhD.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mackay Memorial Hospital
Authority:
Taiwan: Department of Health
Study ID:
MMH-I-S-144
NCT ID:
NCT00366717
Start Date:
June 2005
Completion Date:
January 2006
Related Keywords:
- Cancer
- Cytomegalovirus
- Cancer under chemotherapy
Name | Location |
|---|
